Stockreport

Verastem Oncology submits NDA for ovarian cancer treatment [Yahoo! Finance]

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Avutometinib is an oral rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase clamp while defactinib is an oral selective focal adhesion kinase inhib [Read more]